Thermo Fisher Scientific Inc. (TMO)
NYSE: TMO · Real-Time Price · USD
605.00
+5.31 (0.89%)
Aug 11, 2026, 4:00 PM EDT - Market closed
Thermo Fisher Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 223,697 | 218,002 | 198,090 | 205,229 | 214,217 | 263,079 | |
Market Cap Growth | 28.58% | 10.05% | -3.48% | -4.20% | -18.57% | 42.39% |
Enterprise Value | 262,182 | 247,411 | 223,882 | 232,173 | 240,351 | 293,656 |
Last Close Price | 605.00 | 579.45 | 520.23 | 530.79 | 550.69 | 667.24 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 32.56 | 32.66 | 31.47 | 34.36 | 31.24 | 34.29 |
Forward PE | 23.04 | 24.05 | 22.87 | 24.65 | 25.00 | 32.55 |
PEG Ratio | 2.55 | 3.13 | 2.76 | 2.51 | 1.17 | 1.91 |
PS Ratio | 4.83 | 4.89 | 4.62 | 4.79 | 4.77 | 6.71 |
PB Ratio | 4.25 | 4.08 | 4.00 | 4.39 | 4.87 | 6.45 |
P/FCF Ratio | 30.57 | 34.64 | 27.26 | 29.63 | 31.00 | 38.75 |
P/OCF Ratio | 24.82 | 27.88 | 22.86 | 24.41 | 23.40 | 28.25 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 5.66 | 5.55 | 5.22 | 5.42 | 5.35 | 7.49 |
EV/EBITDA Ratio | 23.65 | 23.50 | 21.43 | 22.62 | 20.41 | 23.27 |
EV/EBIT Ratio | 32.19 | 31.94 | 30.51 | 33.85 | 28.64 | 29.28 |
EV/FCF Ratio | 35.83 | 39.32 | 30.81 | 33.52 | 34.78 | 43.25 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.81 | 0.74 | 0.63 | 0.75 | 0.78 | 0.85 |
Debt / EBITDA Ratio | 3.84 | 3.74 | 2.99 | 3.40 | 2.93 | 2.76 |
Debt / FCF Ratio | 5.81 | 6.26 | 4.30 | 5.04 | 4.99 | 5.14 |
Net Debt / Equity Ratio | 0.73 | 0.55 | 0.52 | 0.57 | 0.59 | 0.75 |
Net Debt / EBITDA Ratio | 3.47 | 2.78 | 2.46 | 2.61 | 2.21 | 2.41 |
Net Debt / FCF Ratio | 5.26 | 4.65 | 3.54 | 3.87 | 3.76 | 4.48 |
Asset Turnover | 0.41 | 0.43 | 0.44 | 0.44 | 0.47 | 0.48 |
Inventory Turnover | 4.96 | 5.06 | 5.00 | 4.80 | 4.86 | 4.31 |
Quick Ratio | 0.90 | 1.25 | 1.03 | 1.16 | 0.98 | 0.93 |
Current Ratio | 1.55 | 1.89 | 1.66 | 1.75 | 1.48 | 1.50 |
Return on Equity (ROE) | 13.24% | 13.10% | 13.22% | 13.22% | 16.76% | 20.48% |
Return on Assets (ROA) | 6.72% | 6.90% | 6.79% | 6.69% | 7.95% | 10.68% |
Return on Invested Capital (ROIC) | 8.20% | 9.06% | 8.93% | 9.11% | 10.80% | 14.95% |
Return on Capital Employed (ROCE) | 8.43% | 8.65% | 8.70% | 8.32% | 10.37% | 14.28% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 3.11% | 3.06% | 3.18% | 2.91% | 3.20% | 2.92% |
FCF Yield | 3.27% | 2.89% | 3.67% | 3.38% | 3.23% | 2.58% |
Dividend Yield | 0.31% | 0.29% | 0.29% | 0.26% | 0.21% | 0.15% |
Payout Ratio | 10.12% | 9.49% | 9.20% | 8.72% | 6.55% | 5.11% |
Buyback Yield / Dilution | 1.44% | 1.31% | 1.29% | 1.52% | 0.76% | 0.50% |
Total Shareholder Return | 1.76% | 1.60% | 1.58% | 1.78% | 0.97% | 0.65% |